Workshop 2024

Programm

Mittwoch, 17. April 2024

10:00
Registrierung und Begrüßungskaffee
10:30
Begrüßungen
Dr. Julia Wagle
Prof. Dr. Stefan Endres
10:35 - 10:50
Introduction:
Engineering therapeutic antibodies

PD Dr. Christian Klein, Schlieren
Bispecifics I
11:00 – 11:20
Kaffeepause
11:20 – 11:35
Bispecific antibodies: The beginnings and the future
Prof. Dr. Patrick A.Baeuerle,
Ludwig-Maximilians-Universität München
11:45 – 12:00
Targeting and exploiting onco-fetal tolerance mechanisms for cancer and autoimmunity
Prof. Dr. Jörg Wischhusen,
Universitätsklinikum Würzburg
12:10 – 12:25
Biomedical potential of bi- and multifunctional immunocytokines
Prof. Dr. Stefan Zielonka,
Global Head of Antibody Discovery & Protein Engineering (ADPE) Research & Development, Merck Healthcare KGaA, Darmstadt, Technische Universität Darmstadt
12:35 – 13:35
Mittagessen
Bispecifics II
13:35 – 13:50
IgA as alternative isotype to treat cancer
Prof. Dr. Jeanette Leusen,
UMC Utrecht
14:00 – 14:15
Multifunctional fusion proteins for the targeted activation and expansion of immune effector cells
Prof. Dr. Matthias Peipp,
Medizinische Klinik II, Sektion für Stammzell- und Immuntherapie Universitätsklinikum Schleswig-Holstein, Kiel
14:25 – 14:40
TCR bispecifics targeting MAGE-A4 and PRAME positive solid tumors
Dr. Sarah Missel,
immatics biotechnologies GmbH, Tübingen
14:50 – 15:05
Breaking new ground in ophthalmology: A gene therapy development for in vivo generation of antibodies
Dr. Mathias Schifflers,
Global Medical Affairs Eyecare AbbVie Deutschland GmbH & Co. KG, Ludwigshafen
15:15 – 15:45
Kaffeepause
Payloads
15:45 – 16:00
Antibody drug conjugates
Dr. Philipp Spycher,
CSO Araris Biotech AG, Zürich
16:10 – 16:25
Targeted radionuclide therapy: How the targeting moiety can impact clinical outcome
Prof. Dr. Theresa Kolben,
Global Head Early Clinical Development Oncology, Bayer AG
16:35 – 16:50
Designed Ankyrin Repeat Protein (DARPin)- based therapies and gene therapy-based in vivo antibody delivery
Prof. Dr. Andreas Plückthun,
Biochemisches Institut Universität Zürich, Zürich
17:00
Schlusswort
Prof. Dr. Stefan Endres